click below
click below
Normal Size Small Size show me how
Arthritic Conditions
NPTE Musculoskeletal
| Question | Answer |
|---|---|
| DJD Characteristic findings | 1. Diminished joint space. 2. Decreased articular cartilage height. 3. Osteophytes. |
| DJD PT goals | 1. Joint protection strategies. 2. Improve joint mechanics & CT function. 3. Aerobic/endurance conditioning |
| Progressive inflammatory DI of unknown etiology that initiall affects axial skeleton | Ankylosing spondylitis |
| Ank Spond Onset age | Age-before 4th decade. Ank Spond sex |
| Ank Spond initial sx | Sx- mid & low back pain >3m, morning stiffness, sacroiliitis |
| Ank Spond results in | Cx and Tx kyphosis and decreased Lx lordosis. Degeneration of peripheral & costovertebral joints in adv. |
| Ank Spond meds used | NSAIDS, Corticosteroids, Cytotoxic drugs, TNF inhibitors (may improve sx) |
| Ank Spond Dx test | HLA-B27 helpful but not diagnostic |
| Ank Spond PT goals | trunk flexibility esp EXT, aerobic conditioning, relaxation and breathing strategies to maintain resp function |
| Genetic DO of purine metabolism with elevated uric acid. UA turn to crystals and deposit in joints and kidneys | Gout |
| Gout most observed in | knee & big toe |
| Gout meds | NSAIDS, COX2, colchicine, corticosteroids, ACTH, allopurinol, probenecid, sulfinpyrazone |
| Gout PT goals | education, early ID |
| Chronic, erosive inflammatory degeneration in digits and axial skeleton assoc with psoriasis | Psoriatic arthritis |
| Psoriatic Arthritis meds | NSAIDs, corticosteroids, DMARDs (slow progression), BRMs – Enbrel/etanercept |
| Psoriatic arthritis PT Goals | joint protection strategies, improve jt mechanics & CT function, aerobic conditioning |
| Chronic systemic DO with symmetrical dysfxn in synovial tissues and articular cartilage | Rheumatoid Arthritis |
| RA joints most effected | hands, wrists, elbows, shoulders, knees, ankles, feet |
| Hand characteristic sx in RA | pannus formation, ulnar drift, volar subluxation of MCP, swan neck deformity, boutonniere deformity, Bouchard’s nodes |
| Pannus | inflammatory granulation tissue on joint surface in RA |
| Bouchard’s nodes | excessive bone formation on dorsal PIP joints |
| RA incidence by sex | women 2-3x more likely |
| JRA | onset of RA prior to 16yr with complete remission in 75% of kids |
| RA Meds | gold compounds, DMARDs (hydroxychloroquine, methotrexate), NSAIDs, immunosuppressivess, corticosteroids |
| RA Dx tests | XR with symmetrical joint involvement, incr WBC & ESR, anemia, RF elevated |